ONYX PHARMACEUTICALS INC Capital Expenditures
ONYX PHARMACEUTICALS INC reported Capital Expenditures of $10.70 million for the 6-month period ending 2013-06-30, per its 10-Q filed 2013-08-09.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2013-08-09
- ONYX PHARMACEUTICALS INC payments to acquire property, plant, and equipment for the quarter ending 2013-06-30 was $4.61M, a 35.88% decline year-over-year.
- ONYX PHARMACEUTICALS INC payments to acquire property, plant, and equipment for the quarter ending 2013-03-31 was $6.09M, a 31.42% decline year-over-year.
- ONYX PHARMACEUTICALS INC payments to acquire property, plant, and equipment for the quarter ending 2012-12-31 was $1.76M, a 52.86% increase year-over-year.
- ONYX PHARMACEUTICALS INC payments to acquire property, plant, and equipment for the quarter ending 2012-09-30 was -$6.45M, a 236.25% decline year-over-year.
- ONYX PHARMACEUTICALS INC payments to acquire property, plant, and equipment for fiscal 2012 was $11.37M, a 24.71% decline from fiscal 2011.
- ONYX PHARMACEUTICALS INC payments to acquire property, plant, and equipment for fiscal 2011 was $15.11M, a 116.12% increase from fiscal 2010.
- ONYX PHARMACEUTICALS INC payments to acquire property, plant, and equipment for fiscal 2010 was $6.99M, a 437.69% increase from fiscal 2009.
- ONYX PHARMACEUTICALS INC payments to acquire property, plant, and equipment for fiscal 2009 was $1.30M.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2013-06-30 | $4.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $10.70M 10-Q · filed 2013-08-09 | $12.46M derived: sum of 3 quarters · filed 2013-08-09 | $6.01M derived: sum of 4 quarters · filed 2013-08-09 |
| 2013-03-31 | $6.09M 10-Q · filed 2013-05-08 | $7.85M derived: sum of 2 quarters · filed 2013-05-08 | $1.40M derived: sum of 3 quarters · filed 2013-05-08 | $8.58M derived: sum of 4 quarters · filed 2013-08-09 |
| 2012-12-31 | $1.76M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | -$4.69M derived: sum of 2 quarters · filed 2013-02-28 | $2.49M derived: sum of 3 quarters · filed 2013-08-09 | $11.37M 10-K · filed 2013-02-28 |
| 2012-09-30 | -$6.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-02 | $733.00K derived: sum of 2 quarters · filed 2013-08-09 | $9.61M 10-Q · filed 2012-11-02 | $10.77M derived: sum of 4 quarters · filed 2013-08-09 |
| 2012-06-30 | $7.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $16.06M 10-Q · filed 2013-08-09 | $17.21M derived: sum of 3 quarters · filed 2013-08-09 | $21.95M derived: sum of 4 quarters · filed 2013-08-09 |
| 2012-03-31 | $8.88M 10-Q · filed 2013-05-08 | $10.03M derived: sum of 2 quarters · filed 2013-05-08 | $14.77M derived: sum of 3 quarters · filed 2013-05-08 | $14.60M derived: sum of 4 quarters · filed 2013-05-08 |
| 2011-12-31 | $1.15M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $5.89M derived: sum of 2 quarters · filed 2013-02-28 | $5.72M derived: sum of 3 quarters · filed 2013-02-28 | $15.11M 10-K · filed 2013-02-28 |
| 2011-09-30 | $4.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-02 | $4.57M derived: sum of 2 quarters · filed 2012-11-02 | $13.96M 10-Q · filed 2012-11-02 | $20.18M derived: sum of 4 quarters · filed 2013-02-28 |
| 2011-06-30 | -$168.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-06 | $9.22M 10-Q · filed 2012-08-06 | $15.44M derived: sum of 3 quarters · filed 2013-02-28 | |
| 2011-03-31 | $9.39M 10-Q · filed 2012-05-04 | $15.61M derived: sum of 2 quarters · filed 2013-02-28 | ||
| 2010-12-31 | $6.22M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $6.99M 10-K · filed 2013-02-28 | ||
| 2010-09-30 | $767.00K 10-Q · filed 2011-11-03 | |||
| 2009-12-31 | $1.30M 10-K · filed 2012-02-27 |